Supplementary Figure S2 from IL4/IL13 Inhibition via Dupilumab Reduces Malignant T-cell Proliferation and Promotes Antitumor Immunity in Sézary Syndrome

Read full text
Authors: Larisa J. Geskin, Alyxzandria M. Gaydosik, Brigit A. Lapolla, Patrizia Fuschiotti
Cited by: 0

Abstract

Figure S2: 0 tSNE-1-50 25-25 0 tSNE-1-50 25-25-25 0 tSNE-1-50 25 0-25-25 0 tSNE-1-50 25-25 0 tSNE-1 25 Grouping of SS and normal blood populations.

Fields of Study & Subjects

Cutaneous lymphoproliferative disorders research Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis

Publication details

Publication date
3 February 2026